MSLP Stock News 9.7400 05/07/2014 22:42:22 Muscle Pharm Corp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Muscle Pharm Corp (MSLP) 9.7400 $MSLP

Why MusclePharm (MSLP) Stock Is Gaining On Monday
at The Street - Mon May 05, 10:01AM CDT
MusclePharm (MSLP) stock is higher today after reporting increases in net sales and net income for the 2014 first quarter.

MusclePharm Reports 2014 First Quarter Financial Results
Marketwire - Mon May 05, 7:03AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company today announced financial results for the first quarter ended March 31, 2014.

MusclePharm to Report 2014 First Quarter Financial Results
Marketwire - Tue Apr 29, 8:04AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the first quarter ended March 31, 2014 on Monday, May 5, 2014, following market close.

Clinical Study of MusclePharm's Award Winning Pre-Workout Supplement Assault(TM) Published in Nutrition Research Journal
Marketwire - Mon Apr 28, 7:02AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that Nutrition Research, an international publication for nutrition to advance food and life science research, published the results of a double-blind placebo-controlled clinical study demonstrating safety and efficacy of MusclePharm's pre-workout supplement Assault(TM).

MusclePharm Announces Key Executive Appointments
Marketwire - Mon Apr 14, 7:01AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced the appointment of Donald W. Prosser as Chief Financial Officer and the promotion of Richard Estalella to President, in addition to his role as Chief Operating Officer.

MusclePharm's FitMiss Brand Signs Jen Selter to Multi-Year Endorsement Deal
Marketwire - Wed Apr 09, 7:03AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced it has signed a multi-year endorsement deal with fitness model and motivator Jen Selter. The agreement adds to the company's presence in the rapidly-expanding world of women's fitness.

MusclePharm Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Mon Mar 31, 7:03AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced financial results for the fourth quarter and full year ended Dec. 31, 2013.

MusclePharm Schedules Fiscal 2013 Fourth Quarter and Full Year Financial Results Press Release and Conference Call for March 31, 2014
Marketwire - Mon Mar 24, 3:30PM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, will report its financial results for the fourth quarter and full year ended Dec. 31, 2013 on Monday, March 31, 2014, prior to market open. The company will also conduct a conference call at 11 a.m. Eastern Time/8 a.m. Pacific Time on the same day to discuss the results.

USA Wrestling Names MusclePharm as Its Exclusive Official Nutritional Supplement Provider
Marketwire - Thu Mar 06, 7:15AM CST
USA Wrestling, the national governing body for wrestling in the United States, has signed MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, as its exclusive official nutritional supplement provider.

The Arnold Schwarzenegger Blueprint by MusclePharm Debuts at BodyBuilding.com
Marketwire - Thu Feb 27, 7:04AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced the launch of The Arnold Schwarzenegger(TM) Blueprint at BodyBuilding.com leading up to the annual Arnold Sports Festival in Columbus, Ohio from Feb. 27 - March 2, 2014.

MusclePharm Sports Science Institute Hosts RockTape Fascial Movement Taping Workshop
Marketwire - Wed Feb 26, 12:30PM CST
MusclePharm Corporation, a leading international, award-winning sports nutrition company, recently hosted a RockTape Fascial Movement Taping workshop to provide training and certification for kinesiology taping techniques. Fascial Movement Taping is a technique based on muscles acting as a chain to create efficient, fluid patterns.

MusclePharm CEO Issues Update Letter to Shareholders
Marketwire - Wed Jan 29, 8:01AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading, award-winning sports nutrition company, today issued the following letter to shareholders from its Chairman and CEO, Brad Pyatt:

MusclePharm Corporation acquires BioZone Pharmaceuticals' assets
M2 - Tue Jan 07, 5:52AM CST
Sports nutrition company MusclePharm Corporation (OTCQB:MSLP) revealed on Monday the completion of the acquisition of essentially all assets of BioZone Pharmaceuticals Inc (OTCBB: BZNE) and its subsidiaries, for 1.2m shares of MusclePharm stock.

MusclePharm Completes Acquisition of Substantially All Assets of BioZone Pharmaceuticals
Marketwire - Mon Jan 06, 7:31AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has completed the acquisition of essentially all assets of BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) and its subsidiaries, for 1.2 million shares of MusclePharm stock.

MusclePharm Names PondelWilkinson as Investor Relations Counsel
Marketwire - Tue Dec 31, 7:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has retained PondelWilkinson Inc. as investor relations counsel.

BioZone Pharmaceuticals, Inc. Completes Balance Sheet Enhancement
Marketwire - Tue Dec 24, 7:00AM CST
BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) announced today that it has completed an enhancement of its balance sheet by eliminating remaining outstanding convertible notes. In the recent transaction, holders of convertible notes with approximately $2.5 million of principal and accrued interest exchanged their securities for shares of common stock. OPKO Health Inc. (NYSE: OPK), a principal shareholder of BioZone Pharmaceuticals and one of the note holders that converted its notes, expressed the view through its Chairman and CEO, Dr. Phillip Frost, that it is optimistic that the planned acquisition of Cocrystal Discovery will enhance shareholder value and enhance BioZone's future prospects as a high growth biotech company.

MusclePharm Announces New $5 Million Share Repurchase Program
Marketwire - Tue Dec 10, 9:01AM CST
MusclePharm Corporation (OTCQB: MSLP) (the "Company", a leading international, award-winning sports nutrition company, announced that its Board of Directors has approved a new 1 year, $5 million program to repurchase shares of MusclePharm's common stock.

BioZone Pharmaceuticals, Inc. Enhances Balance Sheet
Marketwire - Mon Dec 02, 7:46AM CST
BioZone Pharmaceuticals, Inc. (OTCQB: BZNE) announced today that it has enhanced its balance sheet significantly by eliminating outstanding convertible preferred stock. In the recent transaction, holders of convertible preferred stock, with a stated value of $3.5 million and a 10% dividend, exchanged their securities for shares of common stock. Key holders expressed the view that the recently announced merger with Cocrystal Discovery, Inc. is a significant positive development for the Company.

Ultimate Fighting Championship® (UFC), MusclePharm® Renew Partnership
PR Newswire - Mon Dec 02, 6:30AM CST
The Ultimate Fighting Championship® announced a multi-year renewal with MusclePharm® Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company. In addition to branding in the hallowed Octagon®, MusclePharm will be featured in a variety of UFC programming elements ranging from national television broadcasts to Pay-Per-Views and across UFC's digital platforms. The sponsorship also involves special events and the use of official marks and logos for consumer retail promotions including a special Octagon-shaped Fight Pack.

MusclePharm Sports Science Center Hosts Top Researchers, Coaches, Practitioners, Students for National Strength and Conditioning Association Event
PR Newswire - Tue Nov 26, 6:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, recently hosted the National Strength and Conditioning Association (NSCA) Colorado State Clinic which featured leading U.S. researchers and speakers including Dr. Jordan Moon, Colorado State Director, NSCA and Dr. Eric Serrano, Chief Medical Officer, of MusclePharm and Director of the company's Research Institute.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 35

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 19

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 47

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 31

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

ConocoPhillips Prepares for Third Quarter Earnings Report

Updated Category News Views 132

ConocoPhillips Earnings Preview ConocoPhillips (NYSE: COP) is set to unveil its earnings results for the third quarter, drawing significant attention from investors and analysts alike. This report is expected to be released before the opening bell on the designated Thursday. Analysts project that ConocoPhillips will report earnings of $1.41 per share, a decrease from...

Continue Reading
Tesla's FSD Ambitions Shine Amid Market Uncertainty

Updated Category News Views 138

Tesla's Ambitious Goals for Full Self-Driving Technology Tesla, Inc. TSLA is pursuing an ambitious plan to introduce its groundbreaking full self-driving (FSD) technology to markets around the world, with a particular focus on regions in Asia and Europe. What to Anticipate from Tesla's FSD Launch Industry expert Greg Migliore, editor-in-chief of Real Auto Blog, bel

Continue Reading
Centners Pursue $885M Defamation Case Against Local Newspaper

Updated Category News Views 230

Centners File Major Defamation Lawsuit Against a Newspaper Philanthropists and entrepreneurs David and Leila Centner have taken a significant step by initiating a defamation lawsuit against a prominent newspaper and several journalists. They are asserting that the newspaper has intentionally misrepresented public records regarding their generous donation intentions aimed...

Continue Reading
NACCO Industries Reports Solid Performance Amid Challenges

Updated Category News Views 140

NACCO Industries Announces Second Quarter Results NACCO Industries, Inc. (NYSE: NC) has revealed its consolidated results for the three and six months ending in June 2025. The company faced some short-term operational challenges, impacting their ability to meet expected growth targets. Despite this setback, NACCO's versatile sectors remain primed for recovery and...

Continue Reading
Unlocking Income: Earning $500 Monthly from Jefferies Stock

Updated Category News Views 100

Understanding Jefferies Financial Group Inc. Jefferies Financial Group Inc. (NYSE: JEF) is a key player in the financial services sector, known for its robust investment banking operations and diverse financial solutions. With the company's upcoming earnings report for the fourth quarter, there’s excitement surrounding its performance and future potential. Although the...

Continue Reading